| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.003 | 1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |